- Research works
- 33 ▲ 242% vs 2018-21
- Citations
- 482 14.7 per fractional work
- Top-10% rate
- 7.0% all institutions 10.0%
- Open access
- 49% world 40%
- International
- 15% world 18%
Not ranked overall: Xilio Therapeutics (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.
Which fields of science does Xilio Therapeutics (United States) work in?
In 2022-now, 51% of research at Xilio Therapeutics (United States) is in Health Sciences, 42% in Life Sciences. Its largest fields are Medicine (50%), Biochemistry, Genetics and Molecular Biology (25%), Immunology and Microbiology (13%). It does 2.1× the world's share of Life Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 13 fields, with their numbers
- Health Sciences1350.9%
- Medicine1350.0%
- Health Professions00.7%
- Veterinary00.2%
- Life Sciences1041.7%
- Physical Sciences26.7%
- Engineering12.7%
- Chemistry01.5%
- Computer Science01.3%
- Mathematics00.7%
- Materials Science00.4%
- Social Sciences00.7%
- Social Sciences00.7%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 12.6×. Every wedge is a field page.
All 13 fields, with their numbers
- Immunology and Microbiology12.56×3 works
- Biochemistry, Genetics and Molecular Biology4.63×6 works
- Medicine2.60×13 works
- Neuroscience2.31×1 works
- Pharmacology, Toxicology and Pharmaceutics1.88×0 works
- Veterinary1.63×0 works
- Chemistry0.95×0 works
- Mathematics0.56×0 works
- Health Professions0.25×0 works
- Engineering0.18×1 works
- Computer Science0.17×0 works
- Materials Science0.12×0 works
- Social Sciences0.05×0 works
- Immunology and Microbiology 12.6×
- Biochemistry, Genetics and Molecular Biology 4.6×
- Medicine 2.6×
- Neuroscience 2.3×
- Pharmacology, Toxicology and Pharmaceutics 1.9×
- Veterinary 1.6×
- Chemistry 0.9×
- Mathematics 0.6×
- Health Professions 0.2×
- Engineering 0.2×
- Computer Science 0.2×
- Materials Science 0.1×
- Social Sciences 0.1×
Who are the top researchers at Xilio Therapeutics (United States)?
Ranked on the quality score, Carl Uli Bialucha, Manoussa Fanny and Natalia V. Malkova lead among researchers whose main affiliation is Xilio Therapeutics (United States).
- 1
Carl Uli Bialucha
United States · #619,502 worldwide 1.3k citations · 127 works
- 2
Manoussa Fanny
United States · #721,788 worldwide 725 citations · 66 works
- 3
Natalia V. Malkova
United States · #1,274,641 worldwide 1.6k citations · 97 works
- 4
Wilson Tan De Guzman
United States · #1,771,070 worldwide 416 citations · 96 works
- 5
Ekta P. Patel
United States · #2,174,510 worldwide 106 citations · 75 works
- 6
Meghan D. Duncan
United States · #2,674,451 worldwide 202 citations · 20 works
- 7
Parker M. Johnson
United States · #2,689,301 worldwide 388 citations · 91 works
- 8
Kurt A. Jenkins
United States · #2,864,330 worldwide 275 citations · 73 works
Which keywords describe research at Xilio Therapeutics (United States)?
By fractional works in 2022-now, weighted toward what it does more of than the world: Immunotherapy, Monoclonal Antibodies, Cancer Immunotherapy, Fc Receptors, Therapeutic Antibodies, Tumor Regression, Tumor Microenvironment and Innate Immunity.
- Breast Cancer
- PD-1 and PD-L1
- Gene Therapy
- Immunity
- Cancer
- Angiogenesis
- Chimeric Antigen Receptor
- CAR T Cells
- Tumor Microenvironment
- Tumor Regression
- Fc Receptors
- Monoclonal Antibodies
- Immunotherapy
- Cancer Immunotherapy
- Therapeutic Antibodies
- Inflammation
- Innate Immunity
- Cancer Therapy
- Tumor Targeting
- Antigen Presentation
- Dendritic Cells
- Cancer Progression
- Immune Checkpoint Blockade
- Targeted Therapy
Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 24 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 24 words, with their numbers
- Immunotherapy4▲ 21×4 topics
- Monoclonal Antibodies3▲ 145×2 topics
- Cancer Immunotherapy3▲ 81×2 topics
- Fc Receptors3▲ 223×1 topic
- Therapeutic Antibodies3▲ 175×1 topic
- Tumor Regression3▲ 91×2 topics
- Inflammation2▲ 4.0×10 topics
- Tumor Microenvironment2▲ 17×3 topics
- Innate Immunity2▲ 20×2 topics
- CAR T Cells2▲ 90×1 topic
- Cancer Therapy2▲ 11×7 topics
- Chimeric Antigen Receptor2▲ 90×1 topic
- Tumor Targeting2▲ 34×2 topics
- Angiogenesis2▲ 18×5 topics
- Antigen Presentation2▲ 65×1 topic
- Cancer2▲ 4.3×9 topics
- Dendritic Cells2▲ 65×1 topic
- Immunity2▲ 15×2 topics
- Cancer Progression1▲ 26×4 topics
- Gene Therapy1▲ 26×2 topics
- Immune Checkpoint Blockade1▲ 41×1 topic
- PD-1 and PD-L11▲ 41×1 topic
- Targeted Therapy1▲ 19×4 topics
- Breast Cancer1▲ 16×4 topics
Which research topics does Xilio Therapeutics (United States) publish most on?
By volume in 2022-now: Monoclonal and Polyclonal Antibodies Research, CAR-T cell therapy research, Immunotherapy and Immune Responses and Cancer Immunotherapy and Biomarkers.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 3 works
- 2 CAR-T cell therapy research Oncology 2 works
- 3 Immunotherapy and Immune Responses Immunology 2 works
- 4 Cancer Immunotherapy and Biomarkers Oncology 1 works
- 5 Cancer Research and Treatments Biotechnology 1 works
- 6 Cancer Genomics and Diagnostics Cancer Research 1 works
- 7 Microtubule and mitosis dynamics Cell Biology 1 works
- 8 Nanoplatforms for cancer theranostics Biomedical Engineering 1 works
- 9 Cytokine Signaling Pathways and Interactions Oncology 1 works
- 10 Cancer-related Molecular Pathways Oncology 1 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Xilio Therapeutics (United States)'s research output changed?
Output in 2022-2025 was 242% higher than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Waltham
- Brandeis University
- Thermo Fisher Scientific (United States)
- Bentley University
- PerkinElmer (United States)
- Education Development Center
- Foster-Miller (United States)
- Boston Engineering (United States)
- ImmunoGen (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Xilio Therapeutics (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.